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Patients with cardiac tumors may present with cardiovascular related or constitutional
symptoms, but more often than not a cardiac mass is discovered incidentally during an
imaging examination performed for an unrelated indication. Cardiac myxoma is generally
considered to be a surgical emergency. Echocardiography, including the transesophageal
approach, is the most important means of diagnosis; computed tomography and magnetic
resonance imaging.The clinical presentation has changed, and the management of cardiac
myxoma now needs to be reviewed.
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INTRODUCTION
It is called tumor any abnormal growth, whether it be cancerous
or non-cancerous. Tumors originating from the heart are called
primary tumors and can occur in any of its tissues. They can be
cancerous or non-cancerous and are rare. Secondary tumors orig-
inate elsewhere in the body often the lung, breast, blood, or skin
and then spread to the heart (1–3).
Secondary tumors are 30–40 times more common than pri-
mary, but still are considered unusual. Cardiac tumors may not
cause symptoms or may produce a potentially lethal cardiac
dysfunction, mimicking other diseases. Examples of such dis-
orders include sudden heart failure, sudden onset of arrhyth-
mias, and sudden drop in blood pressure due to bleeding in the
pericardium (4–6).
Cardiac tumors are difficult to diagnose both being relatively
uncommon, as its symptoms are similar to those of many other
disorders. To arrive at a diagnosis, it is necessary that the physi-
cian has evidence of their presence. For example, if a person has
cancer elsewhere in the body, but seeks medical attention because
of symptoms related to cardiac dysfunction, the professional may
suspect the presence of a cardiac tumor (5, 6). However, if a cardiac
mass represents a tumor, its etiology can often be determined by
considering four factors: (1) the histology-based likelihood; (2) the
age of the patient at time of presentation; (3) the tumor location;
and (4) non-invasive tissue characterization.
A PubMed, Europubmed search was performed until July 2014
using the terms “cardiac tumors” in combination with the terms
“heart tumors,”“myxomas,” or “cardiac myxomas.”
MYXOMAS
Myxoma is a non-cancerous tumor, and usually has an irregu-
lar shape and a gelatinous consistency. Half of all primary car-
diac tumors are myxomas. Three quarters of myxomas located
in the left atrium, the heart chamber that receives oxygen-rich
blood from the lungs. Generally, the left atrial myxomas origi-
nate from a pedicle and can swing freely with the blood flow,
like a ball attached to a wire. When oscillating, myxomas can
move into and out of the mitral valve next the way between
the left atrium and left ventricle. Cardiac myxomas are usually
solitary and develop in the atria, 75% originating in the left
atrium and 15–20% in the right atrium. They characteristically
arise from or near the interatrial septum at the border of the
fossa ovalis membrane. They occur in all age groups, most fre-
quently between the third and sixth decades. Women are more
commonly affected. Cardiac myxomas range in size from 1 to
15 cm in diameter (7–10).
This oscillation can block and unblock the valve continuously,
so that the blood flow is stopped and restarted intermittently. In
the standing position, the person may faint or episodes of pul-
monary congestion and difficulty breathing, as the force of gravity
causes the tumor to move downwards until the valve opening the
position reduced the symptoms (11).
The tumor can damage the mitral valve and, consequently, a
back flow of blood occurs through this opening, with the pro-
duction of a murmur that the doctor listens with a stethoscope.
Based on the characteristics of the murmur, the doctor con-
siders whether the breath is the result of a flow caused by an
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injury arising out of the tumor, a rare cause or a more com-
mon cause of rheumatic heart disease. Fragments of a myxoma
or blood clots that form on the surface of the myxoma may
detach, move to other organs, and clog blood vessels in these
locations. Symptoms depend on the blocked vessel: obstruction
of a cerebral blood vessel can cause a stroke; obstruction of
a pulmonary vessel can cause pain and bloody sputum (12).
The clinical features of myxomas, like most cardiac tumors, are
determined by their location, size, and mobility. Most patients
present with one or more features of the triad of embolism,
intracardiac obstruction, and constitutional symptoms. Dyspnea
may occur secondary to atrioventricular valve obstruction. Other
symptoms of myxomas include fever, weight loss, fingers and
feet cold and sore when exposed to cold (Raynaud’s phenome-
non), anemia, low platelet count (because platelets are involved
in blood clotting), and symptoms suggestive of severe infection.
Additionally, a myxoma can obstruct blood flow in the heart.
Often they grow from a pedicle (resembling a mushroom) and
are able to swing freely with the flow of the blood. This oscil-
lating motion can obstruct blood flow through the mitral valve,
the passageway between the left atrium and left ventricle. Non-
cancerous less common cardiac tumors, such as fibroids and
rhabdomyomas can grow directly from the cells of the fibrous
tissue of the heart and myocardial cells. Rhabdomyomas, the
second most common type of primary tumor, develop in child-
hood or early adolescence, often associated with a rare childhood
disease called tuberous sclerosis. Other primary cardiac tumors,
such as primary cancer, are extremely rare and, for them, there
is no satisfactory treatment. Children with these tumors have a
life expectancy of <1 year. Several tests are used in the diagno-
sis of cardiac tumors. Often, echocardiography (test that uses
ultrasound waves to investigate the internal structures of the
heart) is used for the delineation of tumors. The ultrasonic waves
can pass through the chest wall or the inside of the esophagus
transesophageal (10, 11).
A catheter inserted through a vein to the heart can be used
to inject substances outlining a heart tumor on radiographs;
but this procedure is less frequently needed. Computed tomog-
raphy (CT) and magnetic resonance imaging (MRI) are also
used. If a tumor is detected, a small sample can be removed
through a special catheter; the sample will then be used to iden-
tify the type of tumor, which will help in selecting the appropriate
treatment (11–13).
Echocardiography provides limited but useful information
regarding tissue characteristics, including echogenicity of the
mass and whether calcification is present. Vascularity can also
be assessed using color flow Doppler and echocardiographic
contrast. Strain imaging also has potential in identifying the
non-contractile nature of masses such as fibromas. CT pro-
vides information regarding vascularity by contrast enhance-
ment, presence of calcification, and presence of fat. Magnetic
resonance imaging also provides information regarding vascu-
larity, presence of fat, degree of tissue edema, and possibly iron
content (14–23).
An isolated non-cancerous primary cardiac tumor can be
removed by surgery, which generally cures the patient. The doctors
do not treat primary tumors when there are many gifts, or treat
tumors that are so great as to preclude removal. Although cardiac
tumors are rare, they are being increasingly recognized ante-
mortem, permitting earlier diagnosis and treatment. The most
likely etiology of a cardiac mass is a thrombus or vegetation. In
the current era, for benign cardiac tumors, an early diagnosis and
appropriate treatment is not only possible but often curative.
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